Steffen Schmitt

4.8k total citations
28 papers, 1.9k citations indexed

About

Steffen Schmitt is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Steffen Schmitt has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Steffen Schmitt's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (8 papers) and Immunotherapy and Immune Responses (5 papers). Steffen Schmitt is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (8 papers) and Immunotherapy and Immune Responses (5 papers). Steffen Schmitt collaborates with scholars based in Germany, United States and Croatia. Steffen Schmitt's co-authors include Michael Stassen, Tobias Bopp, Edgar Schmitt, Matthias Klein, Helmut Jonuleit, Manfred Blessing, Samuel Huber, Christoph Schramm, Hansjörg Schild and Valeska Heib and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Steffen Schmitt

28 papers receiving 1.9k citations

Peers

Countries citing papers authored by Steffen Schmitt

Since Specialization

Citations

This map shows the geographic impact of Steffen Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Schmitt more than expected).

Fields of papers citing papers by Steffen Schmitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Schmitt. The network helps show where Steffen Schmitt may publish in the future.

Co-authorship network of co-authors of Steffen Schmitt

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Schmitt. A scholar is included among the top collaborators of Steffen Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Schmitt. Steffen Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intermediate monocytes exhibit higher levels of TLR2, TLR4 and CD64 early after congenital heart surgery 2020 ·Cytokine ·(unknown), Victoria C. Ziesenitz, (unknown), (unknown), (unknown), (unknown), (unknown), Nicole Ritz, Tsvetomir Loukanov, Steffen Schmitt, Matthias Gorenflo	2
2	Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133+ human colorectal cancer cells 2016 ·BMC Cancer ·Johannes Klose, (unknown), (unknown), Steffen Schmitt, (unknown), Ying Shen, Thomas Schmidt, Ulrike Heger, Martin Schneider, Alexis Ulrich	44
3	A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells 2013 ·BMC Cancer ·Martin Grimm, Steffen Schmitt, Peter Teriete, Thorsten Biegner, Arnulf Stenzl, Jörg Hennenlotter, (unknown), Adelheid Munz, (unknown), Klemens König, Jörg Sänger, Oliver Feyen, (unknown), Siegmar Reinert, Johannes F. Coy	50
4	A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors 2011 ·Pathology ·Aurélie Ernst, Maximilian Aigner, Susumu Nakata, Felix B. Engel, Magdalena Schlotter, Matthias Kloor, Karsten Brand, Steffen Schmitt, Gunnar Steinert, Nuh N. Rahbari, Moritz Koch, Bernhard Radlwimmer, Jürgen Weitz, Peter Lichter	14
5	Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent 2010 ·Cancer Biology & Therapy ·Svitlana P. Grekova, Marc Aprahamian, Nathalia A. Giese, Steffen Schmitt, Thomas Giese, Christine S. Falk, Laurent Daeffler, Celina Cziepluch, Jean Rommelaere, Zahari Raykov	39
6	In vivo fate mapping with SCL regulatory elements identifies progenitors for primitive and definitive hematopoiesis in mice 2009 ·Mechanisms of Development ·Ernesto Bockamp, (unknown), Stefan Liebner, Steffen Schmitt, Nina Cabezas‐Wallscheid, Rosario Heck, (unknown), Barbara Oesch‐Bartlomowicz, Christof Rickert, María J. Sánchez, Jan G. Hengstler, Bernd Kaina, Anne Wilson, Andreas Trumpp, Leonid Eshkind	3
7	Protective role of nuclear factor of activated T cells 2 in CD8+ long-lived memory T cells in an allergy model 2008 ·Journal of Allergy and Clinical Immunology ·(unknown), Joachim Maxeiner, Steffen Schmitt, Petra Scholtes, Michael Hausding, Hans A. Lehr, Laurie H. Glimcher, Susetta Finotto	27
8	P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25− T Cells into iTreg 2008 ·PLoS ONE ·Samuel Huber, Jörg Schrader, Gerhard Fritz, (unknown), Steffen Schmitt, Ari Waisman, Stefan Lüth, Manfred Blessing, Johannes Herkel, Christoph Schramm	50
9	Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression 2007 ·The Journal of Experimental Medicine ·Tobias Bopp, Christian Becker, Matthias Klein, Stefan Klein-Heßling, Alois Palmetshofer, Edgar Serfling, Valeska Heib, Marc A. Becker, Jan Kubach, Steffen Schmitt, Sabine Stoll, Hansjörg Schild, Martin S. Staege, Michael Stassen, Helmut Jonuleit, Edgar Schmitt	473
10	Generation and characterization of tTS‐H4: a novel transcriptional repressor that is compatible with the reverse tetracycline‐controlled TET‐ON system 2007 ·The Journal of Gene Medicine ·Ernesto Bockamp, (unknown), (unknown), Andriy Khobta, Marko Maringer, Marco Reis, Rosario Heck, Nina Cabezas‐Wallscheid, Bernd Epe, Barbara Oesch‐Bartlomowicz, Bernd Kaina, Steffen Schmitt, Leonid Eshkind	6
11	Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues 2007 ·Physiological Genomics ·(unknown), (unknown), Leonid Eshkind, Steffen Schmitt, (unknown), (unknown), Eric M. Bindels, Jos Jonkers, Paul Krimpenfort, Ralph Meuwissen, (unknown), Axel Bex, Anton Berns, Ernesto Bockamp	155
12	Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells 2006 ·Blood ·Ernesto Bockamp, (unknown), Marko Maringer, Rosario Heck, (unknown), (unknown), (unknown), Rüdiger Alt, Michael Cross, Rolf Sprengel, Udo F. Hartwig, Bernd Kaina, Steffen Schmitt, Leonid Eshkind	16
13	Premature Senescence Is a Primary Fail-safe Mechanism of ERBB2-Driven Tumorigenesis in Breast Carcinoma Cells 2005 ·Cancer Research ·(unknown), Ekkehart Lausch, (unknown), Steffen Schmitt, Thorsten Enklaar, Dirk Reutzel, (unknown), Peter Schmidtke, Marko Maringer, Ilka B. Schiffer, (unknown), Jan G. Hengstler, Gerhard Fritz, Ernesto Bockamp, Dirk Prawitt, Bernhard Zabel, Christian Spangenberg	70
14	Sclérose tubéreuse de Bourneville 2005 ·F. Ballanger, G. Quéreux, J.‐F. Stalder, Steffen Schmitt, Sébastien Jacquemont	1
15	Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2 2005 ·Free Radical Biology and Medicine ·Andrei L. Kleschyov, Susanne Strand, Steffen Schmitt, (unknown), (unknown), Nikolajs Sjakste, Andreas Daiber, Victor Umansky, Thomas Münzel	64
16	Lovastatin stimulates p75 TNF receptor (TNFR2) expression in primary human endothelial cells 2005 ·International Journal of Molecular Medicine ·Tobias Nübel, Steffen Schmitt, Bernd Kaina, Gerhard Fritz	8
17	Differential Regulatory Capacity of CD25+ T Regulatory Cells and Preactivated CD25+ T Regulatory Cells on Development, Functional Activation, and Proliferation of Th2 Cells 2004 ·The Journal of Immunology ·Michael Stassen, Helmut Jonuleit, Christian D. Muller, Matthias Klein, Christoph Richter, Tobias Bopp, Steffen Schmitt, Edgar Schmitt	88
18	Cutting Edge: TGF-β Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells 2004 ·The Journal of Immunology ·Samuel Huber, Christoph Schramm, Hans A. Lehr, Amrit Mann, Steffen Schmitt, Christoph Becker, Martina Protschka, Peter R. Galle, Markus F. Neurath, Manfred Blessing	328
19	Human CD25⁺ regulatory T cells: two subsets defined by the integrins α₄β₇ or α₄β₁ confer distinct suppressive properties upon CD4⁺ T helper cells 2004 ·European Journal of Immunology ·Michael Stassen, (unknown), Tobias Bopp, Christoph Richter, Christian Müller, Jan Kubach, Christian Becker, Jürgen Knop, Alexander Enk, Steffen Schmitt, Edgar Schmitt, Helmut Jonuleit	134
20	Two separable T cell receptor signals reconstitute positive selection of CD4 lineage T cells in vivo 1997 ·European Journal of Immunology ·Steffen Schmitt, (unknown), Bruno Kyewski	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact